| Managing neurological toxicities associated with ALL therapy | Christina Halsey (UK) | |
| Vaccine development in neuroblastoma and beyond | Nai-Kong Cheung (US) | |
| Stopping TKIs in CML – decision making and weighing risks/benefits | Nobuko Hijiya (US) | |
| Engaging children and adolescents with cancer and their parents in clinical research | Natalie Bradford (Australia) | |
| Proton therapy and implications from a psychooncology perspective | Lisa Kahalley (US) | |
| PROS: D’Angio Lecture | Jeannette Parkes (South Africa) | |
| IPSO – Extreme Hepatic resection versus transplantation for hepatic tumours in childhood | Christoph Chardot (France) | |
| Novel theragnostics in paediatric oncology | Max M. Van Noesel (The Netherlands) |
| Advances in the management of retinoblastoma |
| New trends in ependymoma diagnosis and treatment |
| Advanced directives including DNR – perspectives from different disciplines, children and parents |
| Nursing – retention and specialization in pediatric oncology |
| Minimizing patient distress with screening and interventions – a global perspective |
| St. Baldrick’s Lecture: Therapy for Burkitt lymphoma – HIC and LMICs |
| SIOP/PROS/IPSO symposium – The multimodal management of pulmonary metastases |
| PROS- Advances in the Multimodality management of Wilms Tumors |
| Role of surgery versus radiotherapy for Ewing Sarcoma |
Debate: Is it ethical to give adapted treatment in low and middle income countries Andrea Biondi (Italy) and Michael Sullivan (Australia)
| Everything you wanted to know about immunotherapy basic sciences but were afraid to ask | Holger Lode (Germany) |
| 2021 WHO classification for brain tumors | David Ellison (US) |
| Drug acquisition and supply chain management – what if I can’t get the drug? | Vikramjit S. Kanwar (India) |
| Role of precision medicine in LMICs | Nmazuo Ozuah (US) |
| Vascular access challenges and solutions | Sajid Qureshi (India)
Gitte Peterson (Denmark) |
| Tumor Board – Leukemia | Mireia Camós (Spain)
Johann Hizler Canada) Henrik Hasle (Denmark) David Veron (Argentina) |
| Tumor Board – Solid Tumors | Mariana Varela (Argentina)
David H. Abramson (US) Franics L. Munier (Switzerland) Francois Doz (France) |
